Search

Your search keyword '"John Q Trojanowski"' showing total 1,605 results

Search Constraints

Start Over You searched for: Author "John Q Trojanowski" Remove constraint Author: "John Q Trojanowski"
1,605 results on '"John Q Trojanowski"'

Search Results

1. Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis

2. Cerebrovascular disease lesions are additive and tied to vascular risk factors and cognitive impairment

3. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

4. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

5. Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease

6. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.

7. The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.

8. Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.

9. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.

10. Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

12. An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.

13. Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.

14. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.

15. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.

16. The Role of Apolipoprotein E (APOE) Genotype in Early Mild Cognitive Impairment (E-MCI)

17. Cerebrospinal Fluid Biomarkers for Differentiation of Frontotemporal Lobar Degeneration from Alzheimer’s Disease

18. Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI.

19. Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.

20. Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

21. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis.

22. Astrocyte senescence as a component of Alzheimer's disease.

23. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.

24. P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating.

25. α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice

26. Improved Segmentation of Deep Sulci in Cortical Gray Matter Using a Deep Learning Framework Incorporating Laplace's Equation.

27. Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease

28. Plasma phosphorylated tau181 predicts cognitive and functional decline

29. Unfolding the Medial Temporal Lobe Cortex to Characterize Neurodegeneration Due to Alzheimer's Disease Pathology Using Ex vivo Imaging.

30. 3D Mapping of TAU Neurofibrillary Tangle Pathology in the Human Medial Temporal Lobe.

31. Building an Ex Vivo Atlas of the Earliest Brain Regions Affected by Alzheimer's Disease Pathology.

32. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated

33. Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein

34. Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies

36. Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders

37. TREM2 risk variants are associated with atypical Alzheimer’s disease

38. Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy

39. Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue

40. Genetic prediction of impulse control disorders in Parkinson's disease

41. Creating the Pick’s disease International Consortium: Association study of MAPT H2 haplotype with risk of Pick’s disease

42. Preclinical characterization and IND‐enabling safety studies for PNT001, an antibody that recognizes cis ‐pT231 tau

43. New insights into the genetic etiology of Alzheimer's disease and related dementias

44. Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes

45. Antemortem network analysis of spreading pathology in autopsy-confirmed frontotemporal degeneration

46. ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease

47. Deep learning pipeline for cortical gray matter segmentation and thickness analysis in Ultra High Resolution T2w 7 Tesla Ex vivo MRI across neurodegenerative diseases reveals associations with underlying neuropathology

48. Plasma GFAP:NfL discriminates FTLD‐tau from FTLD‐TDP

49. Linking histology to post‐mortem 7T MRI measures of neurodegeneration

50. Deep Learning for Ultra High Resolution T2‐weighted 7 Tesla Ex vivo Magnetic Resonance Imaging Reveals Differential Subcortical Atrophy across Neurodegenerative Diseases

Catalog

Books, media, physical & digital resources